Skip to main content

RHUMBLINE ADVISERS

Position in CRL — Charles River Laboratories International, Inc.

CIK 1115418 BOSTON, MA

Position in CRL

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$15,822,735
-$1,833,040 QoQ
Shares Held
91,726
+3.6% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 73.44155419401261.ToString("F0")% Shared 0.ToString("F0")% None 26.558445805987397.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,138,138,827 across 32 Diagnostics & Research names. CRL ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,822,735 91,726
2025-12-31 $17,655,775 88,509
2025-09-30 $15,109,185 96,569
2025-06-30 $14,435,895 95,142
2025-03-31 $13,054,599 86,730
2024-12-31 $15,381,795 83,325
2024-09-30 $17,005,207 86,334
2024-06-30 $18,238,121 88,286
2024-03-31 $23,583,758 87,041
2023-12-31 $20,595,640 87,122
2023-09-30 $16,706,707 85,247
2023-06-30 $17,951,145 85,380
2023-03-31 $18,742,821 92,869
2022-12-31 $18,747,244 86,036
2022-09-30 $16,397,572 83,321
2022-06-30 $17,694,677 82,697
2022-03-31 $20,866,967 73,483
2021-12-31 $32,240,311 85,568
2021-09-30 $33,521,596 81,231
2021-06-30 $31,331,854 84,699
2021-03-31 $39,132,266 135,018
2020-12-31 $34,445,949 137,861
2020-09-30 $32,164,958 142,040
2020-06-30 $25,660,484 147,178
2020-03-31 $17,006,292 134,746